Sumitomo Mitsui Trust Holdings, Inc. Inovio Pharmaceuticals, Inc. Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 30, 2020	SELL	$9.57 - $27.05 $5.67 Million - $16 Million	-592,303 Closed	0 $0
Q2 2020 Jul 27, 2020	SELL	$7.14 - $31.69 $15.1 Million - $67.2 Million	-2,121,681 Reduced 78.18%	592,303 $16 Million
Q1 2020 Apr 27, 2020	SELL	$2.98 - $14.09 $6.95 Million - $32.9 Million	-2,333,624 Reduced 46.23%	2,713,984 $20.2 Million
Q4 2019 Jan 31, 2020	SELL	$1.97 - $3.72 $214,221 - $404,520	-108,742 Reduced 2.11%	5,047,608 $16.7 Million
Q3 2019 Oct 31, 2019	BUY	$2.05 - $3.02 $558,112 - $822,195	272,250 Added 5.57%	5,156,350 $10.6 Million
Q2 2019 Jul 29, 2019	BUY	$2.29 - $4.1 $3.88 Million - $6.95 Million	1,694,891 Added 53.14%	4,884,100 $14.4 Million
Q1 2019 May 08, 2019	BUY	$3.34 - $5.1 $10.7 Million - $16.3 Million	3,189,209 New	3,189,209 $11.9 Million

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $990M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.